Anixa Biosciences, Inc. (ANIX) vs electroCore, Inc. (ECOR)

A side-by-side comparison of Anixa Biosciences, Inc. and electroCore, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANIX vs ECOR

growth of $100 · dividends reinvested · last 8y
ANIX -7.2% (-0.9%/yr)ECOR -96.6% (-34.5%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002020202220242026$93$3
ANIX ECOR

ANIX vs ECOR: by the numbers

  • •ANIX is the larger company ($98M vs $92M market cap).
  • •Both run net losses; ANIX's is the smaller (0.00% vs -39.96% net margin).

Metrics side by side

Valuation

MetricANIXECOR
P/S ratioN/A2.48
P/B ratio6.79N/A

Profitability

MetricANIXECOR
Gross margin0.00%87.06%
Operating margin0.00%-37.64%
Net margin0.00%-39.96%
ROE-72.02%N/A
ROIC-82.35%-217.73%

Growth (annualized)

MetricANIXECOR
Revenue CAGR (5Y)N/A52.51%
Total return CAGR (5Y)-8.26%-8.10%

Frequently asked

How have ANIX and ECOR total returns compared?
Over the past 5 years, ANIX delivered -8.26% and ECOR delivered -8.10% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.